AIM
ITOS

Aigen Investment Management’s iTeos Therapeutics ITOS Stock Holding History

Aigen Investment Management’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,291
Closed -$113K – 934
2025
Q2 		$113K Buy
+11,291
New +$91K 0.02% 711

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Aigen Investment Management's ITOS Position: Q3 2025 in Review

Aigen Investment Management sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 11,291 shares — an estimated $113K sold.

Aigen Investment Management first reported a position in ITOS in Q2 2025 and held it in 1 quarter. The position peaked at $113K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

  • Aigen Investment Management reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Aigen Investment Management sold 11,291 iTeos Therapeutics shares in Q3 2025, an estimated $113K.
  • Aigen Investment Management first reported a position in iTeos Therapeutics in Q2 2025 and held it in 1 quarter.
  • Aigen Investment Management's iTeos Therapeutics position peaked at $113K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Aigen Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.